Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immix Biopharma, Inc.

1.65
+0.04002.48%
Post-market: 1.61-0.0450-2.73%19:28 EDT
Volume:33.06K
Turnover:55.56K
Market Cap:45.74M
PE:-2.16
High:1.72
Open:1.57
Low:1.57
Close:1.61
1D
5D
D
W
M
Q
Y
1m
5m
10m
15m
30m
1h
2h
More
1D
5D
D
W
M
Q
Y
1m
5m
10m
15m
30m
1h
2h
Mar 24, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Nov 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 26, 2024

Major Issues Report

Form 8-K - Current report
Jul 22, 2024

Major Issues Report

Form 8-K - Current report
Jul 22, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 14, 2024

Major Issues Report

Form 8-K - Current report
May 20, 2024

Major Issues Report

Form 8-K - Current report
May 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 16, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 07, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 06, 2024

Major Issues Report

Form 8-K - Current report
Feb 05, 2024

Major Issues Report

Form 8-K - Current report
Nov 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 26, 2023

Correspondence

Form CORRESP - Correspondence
Aug 29, 2023

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Aug 22, 2023

Major Issues Report

Form 8-K - Current report
Aug 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 14, 2023

Major Issues Report

Form 8-K - Current report

If the download button clicks without skipping, click on the top right menu and select "Open in Browser."